Search consultations

Consultation

Proposal to fully fund Mercilon 28 for oral contraception

NZNO welcomes your feedback on PHARMAC’s proposal to increase the subsidy to fully fund ethinyloestradiol 20 mcg with desogestrel 150 mcg tablets and 7 inert tablets (Brand name: Mercilon 28) for oral contraception.

There would be no change for individuals on other fully funded combined oral contraceptives.

Further details about the proposal are available here on the PHARMAC website.

Please note the short timeframe for feedback.

Please send feedback to Policy.Analysts@nzno.org.nz by 9 March 2021.

Notify me when this page changes

Enter your email address below to receive alerts when this page is updated.

Sign up below to receive an email when we update this page

Email:  
Captcha:
CAPTCHA image
Enter the code shown above in the box below.